Comparison of the effects of bimatoprost and timolol on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: A prospective, open-label, randomized, two-arm, parallel-group study.

[1]  M. L. Rosa Glaucoma crónico de ángulo abierto , 2005 .

[2]  R. Stodtmeister,et al.  Autoregulation of ocular blood flow during changes in intraocular pressure , 1985, Graefe's Archive for Clinical and Experimental Ophthalmology.

[3]  Y. Bilgili,et al.  Short‐term effect of latanoprost on ocular circulation in ocular hypertension , 2004, Clinical & experimental ophthalmology.

[4]  G. Richard,et al.  Okuläre Hämodynamik beim Normaldruckglaukom: Effekte von Bimatoprost , 2004 .

[5]  L. Verma,et al.  Increased periocular pigmentation with ocular hypotensive lipid use in African Americans. , 2004, American journal of ophthalmology.

[6]  G. Richard,et al.  [Ocular hemodynamics in normal tension glaucoma: effect of bimatoprost]. , 2004, Klinische Monatsblatter fur Augenheilkunde.

[7]  W. C. Stewart,et al.  Corneal Punctate Staining With Latanoprost, Bimatoprost, and Travoprost in Healthy Subjects , 2003, Journal of glaucoma.

[8]  R. Sihota,et al.  Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma. , 2003, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[9]  L. Roberts,et al.  Hydrolysis of bimatoprost (Lumigan) to its free acid by ocular tissue in vitro. , 2003, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[10]  J. Crider,et al.  Human trabecular meshwork cell responses induced by bimatoprost, travoprost, unoprostone, and other FP prostaglandin receptor agonist analogues. , 2003, Investigative ophthalmology & visual science.

[11]  N. Sharif,et al.  Bimatoprost (Lumigan®) is an agonist at the cloned human ocular FP prostaglandin receptor: real-time FLIPR-based intracellular Ca2+ mobilization studies , 2003 .

[12]  A. Fea,et al.  Intraocular pressure and progression of visual field damage. , 2002, Acta ophthalmologica Scandinavica. Supplement.

[13]  A. R. Gaudio,et al.  Cystoid macular edema associated with ocular hypotensive lipids. , 2002, American journal of ophthalmology.

[14]  N. Sharif,et al.  Bimatoprost and its free acid are prostaglandin FP receptor agonists. , 2001, European journal of pharmacology.

[15]  R. Brubaker Mechanism of action of bimatoprost (Lumigan). , 2001, Survey of ophthalmology.

[16]  J. Brandt,et al.  Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. , 2001, Survey of ophthalmology.

[17]  R. Lai,et al.  The pharmacology of bimatoprost (Lumigan). , 2001, Survey of ophthalmology.

[18]  R. Brubaker,et al.  Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. , 2001, American journal of ophthalmology.

[19]  S. Hayreh Blood supply of the optic nerve head. , 1996, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[20]  S. Drance,et al.  Pharmacology of Glaucoma , 1992 .

[21]  T. Tokoro,et al.  [Effects of timolol and carteolol on ocular pulsatile blood flow]. , 1992, Nippon Ganka Gakkai zasshi.

[22]  D. Trew,et al.  Postural studies in pulsatile ocular blood flow: II. Chronic open angle glaucoma. , 1991, The British journal of ophthalmology.

[23]  M. Langham The influence of timolol clonidine and aminoclonidine on ocular blood flow in the rabbit and human subjects , 1990 .

[24]  A. Bill,et al.  Control of retinal and choroidal blood flow , 1990, Eye.

[25]  P. Schilder Ocular blood flow changes with increased vascular resistance external and internal to the eye , 1989, Acta ophthalmologica. Supplement.

[26]  R. Stodtmeister,et al.  Effect of different antiglaucomatous drugs on ocular perfusion pressures. , 1988, Journal of ocular pharmacology.